# Bowel Obstruction â€“ RRT Protocol with Virtua Voorhees Addenda

**Primary Guideline:** 2025 World Society of Emergency Surgery (WSES) Updated Bologna Guidelines for Adhesive Small Bowel Obstruction
**Official Source:** https://wjes.biomedcentral.com/articles/10.1186/s13017-018-0185-2
**Supporting Guidelines:**
- 2025 American College of Surgeons Updated Clinical Practice Guidelines for Small Bowel Obstruction
- 2025 Prospective Multi-Center Study on Compliance with Bologna Guidelines (SnapSBO)
- 2024 European Association for Endoscopic Surgery Guidelines on Laparoscopic Management of SBO

## ENHANCED MERMAID FLOWCHART ALGORITHM

~~~mermaid
graph TD
    A["Suspected Bowel Obstruction<br/>Abdominal Pain + Distension"] --> B["Immediate Assessment<br/>NPO + IV + Labs + KUB"]
    
    B --> C["CT Abdomen/Pelvis<br/>With IV Contrast"]
    
    C --> D{"Obstruction<br/>Confirmed?"}
    
    D -->|NO| E["Alternative Diagnosis<br/>Ileus vs Other Causes"]
    D -->|YES| F["Severity Assessment<br/>Complete vs Partial"]
    
    E --> G["Treat Underlying Cause<br/>Pro-motility Agents"]
    F --> H{"Emergency Surgery<br/>Indications Present?"}
    
    H -->|YES| I["Urgent OR<br/>< 6 Hours"]
    H -->|NO| J["Bologna Protocol<br/>Conservative Management"]
    
    I --> K["Laparoscopic vs Open<br/>Based on Complexity"]
    J --> L["NGT Decompression<br/>+ Water-Soluble Contrast"]
    
    L --> M["SBFT Protocol<br/>Serial Imaging q2-8-24h"]
    K --> N["Post-Operative<br/>Recovery Protocol"]
    
    M --> O{"Contrast in Colon<br/>Within 24h?"}
    
    O -->|YES| P["Resolution Confirmed<br/>Begin Diet Advancement"]
    O -->|NO| Q{"48-72 Hour<br/>Decision Point"}
    
    Q -->|IMPROVING| R["Continue Conservative<br/>Daily Assessment"]
    Q -->|STATIC/WORSE| S["Surgical Consultation<br/>Operative Planning"]
    
    P --> T["Discharge Planning<br/>Diet Tolerance"]
    R --> U{"Day 5 Assessment<br/>Final Decision"}
    S --> V["Laparoscopic Approach<br/>If Appropriate"]
    
    U -->|SUCCESS| T
    U -->|FAILURE| V
    
    V --> W["Post-Op Recovery<br/>Enhanced Protocols"]
    N --> W
    W --> X["ICU/Floor Care<br/>Based on Complexity"]
    T --> Y["Home with Follow-up<br/>Return Precautions"]
    
    G --> Z["Symptom Resolution<br/>Address Underlying Cause"]
    X --> AA["Disposition Based<br/>on Recovery"]
    Y --> BB["Quality Metrics<br/>Outcome Tracking"]
    Z --> BB
    AA --> BB
    
    style A fill:#ffcccc
    style I fill:#ff6666
    style L fill:#ffe6cc
    style M fill:#fff2cc
    style S fill:#ffaaaa
    style V fill:#ccffcc
    style BB fill:#ccffee
~~~

## STREAMLINED DYNAMIC CARD SYSTEM

### Card 0 â€“ Bowel Obstruction Recognition & Initial Assessment (Node A â†’ B)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¤¢ BOWEL OBSTRUCTION RRT ACTIVATION     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Recognition criteria (2025 update):  â”‚
â”‚ â€¢ Abdominal pain with distension        â”‚
â”‚ â€¢ Nausea/vomiting (especially bilious)  â”‚
â”‚ â€¢ Constipation/obstipation              â”‚
â”‚ â€¢ High-pitched bowel sounds or absence  â”‚
â”‚ â€¢ History of abdominal surgery          â”‚
â”‚                                         â”‚
â”‚ ğŸš¨ Immediate interventions:             â”‚
â”‚ â€¢ NPO status (strict nothing by mouth)  â”‚
â”‚ â€¢ Large-bore IV access (18G minimum)    â”‚
â”‚ â€¢ Isotonic fluid resuscitation          â”‚
â”‚ â€¢ STAT laboratory studies               â”‚
â”‚ â€¢ Plain abdominal radiographs (KUB)     â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Essential labs (STAT):               â”‚
â”‚ â€¢ CBC with differential                 â”‚
â”‚ â€¢ Complete metabolic panel              â”‚
â”‚ â€¢ Lactate level                         â”‚
â”‚ â€¢ Lipase (if epigastric pain)           â”‚
â”‚                                         â”‚
â”‚ [Next: CT imaging â–¶]                    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 1 â€“ CT Assessment & AAST Grading (Node C â†’ F)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“¸ CT ABDOMEN/PELVIS & AAST GRADING     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ Key imaging findings:                â”‚
â”‚ â€¢ **Dilated small bowel:** >2.5-3cm diameterâ”‚
â”‚ â€¢ **Transition point:** Site of obstructionâ”‚
â”‚ â€¢ **Decompressed distal bowel**         â”‚
â”‚ â€¢ **Air-fluid levels** on coronal views â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š AAST Small Bowel Obstruction Grading[27]:â”‚
â”‚ â€¢ **Grade I:** Partial SBO, minimal distensionâ”‚
â”‚ â€¢ **Grade II:** Complete SBO, viable bowelâ”‚
â”‚ â€¢ **Grade III:** Complete SBO, compromised but viableâ”‚
â”‚ â€¢ **Grade IV:** Complete SBO, nonviable bowel/localized perforationâ”‚
â”‚ â€¢ **Grade V:** SB perforation, diffuse peritonitisâ”‚
â”‚                                         â”‚
â”‚ ğŸš¨ High-risk CT findings:               â”‚
â”‚ â€¢ Closed-loop configuration             â”‚
â”‚ â€¢ Bowel wall thickening >3mm            â”‚
â”‚ â€¢ Mesenteric edema/stranding            â”‚
â”‚ â€¢ Pneumatosis intestinalis              â”‚
â”‚ â€¢ Free air (perforation)                â”‚
â”‚ â€¢ Ascites (especially if loculated)     â”‚
â”‚                                         â”‚
â”‚ [Next: Emergency surgery assessment â–¶] â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Initial Assessment]       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2A â€“ Emergency Surgery Indications (Node H â†’ I)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ EMERGENCY SURGICAL INDICATIONS       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ”´ Absolute indications (immediate OR):  â”‚
â”‚ â€¢ **Peritonitis:** Rebound/guarding     â”‚
â”‚ â€¢ **Free air:** Perforation confirmed   â”‚
â”‚ â€¢ **Hemodynamic instability**           â”‚
â”‚ â€¢ **Closed-loop obstruction**           â”‚
â”‚ â€¢ **Strangulation signs:** Fever, tachycardia, leukocytosisâ”‚
â”‚ â€¢ **AAST Grade IV-V**                   â”‚
â”‚                                         â”‚
â”‚ ğŸŸ¡ Relative indications (urgent OR <6h): â”‚
â”‚ â€¢ **Bowel wall pneumatosis**            â”‚
â”‚ â€¢ **Mesenteric ischemia signs**         â”‚
â”‚ â€¢ **Incarcerated hernia** (irreducible) â”‚
â”‚ â€¢ **Transition point with concerning features**â”‚
â”‚ â€¢ **Failed previous conservative management**â”‚
â”‚                                         â”‚
â”‚ âš ï¸ Laboratory red flags[27]:            â”‚
â”‚ â€¢ Lactate >2.5 mmol/L                   â”‚
â”‚ â€¢ WBC >15,000 with left shift           â”‚
â”‚ â€¢ Metabolic acidosis (pH <7.35)         â”‚
â”‚ â€¢ Rising creatinine (>30% from baseline)â”‚
â”‚                                         â”‚
â”‚ ğŸ“ Team activation:                     â”‚
â”‚ â€¢ Surgery STAT call                     â”‚
â”‚ â€¢ OR notification                       â”‚
â”‚ â€¢ Anesthesia consultation               â”‚
â”‚                                         â”‚
â”‚ [Next: Urgent operative management â–¶]  â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: CT Assessment]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2B â€“ Bologna Conservative Protocol (Node J â†’ L)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ BOLOGNA PROTOCOL IMPLEMENTATION      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ âœ… Inclusion criteria (2025 evidence)[27]:â”‚
â”‚ â€¢ **Adhesive SBO** (prior abdominal surgery)â”‚
â”‚ â€¢ **No peritoneal signs**               â”‚
â”‚ â€¢ **Hemodynamically stable**            â”‚
â”‚ â€¢ **AAST Grade I-II**                   â”‚
â”‚ â€¢ **Partial obstruction** or early completeâ”‚
â”‚                                         â”‚
â”‚ ğŸ’§ Initial management (first 2 hours):  â”‚
â”‚ â€¢ **IV fluid resuscitation:** NS/LR 150-250mL/hrâ”‚
â”‚ â€¢ **Electrolyte correction:** K+, Mg2+, PO4â”‚
â”‚ â€¢ **Bladder catheterization** (monitor UOP)â”‚
â”‚ â€¢ **Pain management:** Avoid opioids initiallyâ”‚
â”‚                                         â”‚
â”‚ ğŸ”„ NGT placement protocol:              â”‚
â”‚ â€¢ **Indication:** Vomiting or gastric distensionâ”‚
â”‚ â€¢ **Size:** 16-18Fr Salem sump preferredâ”‚
â”‚ â€¢ **Confirmation:** CXR to verify placementâ”‚
â”‚ â€¢ **Suction:** Low intermittent (-40 to -60 mmHg)â”‚
â”‚                                         â”‚
â”‚ â±ï¸ Bologna timeline expectations:       â”‚
â”‚ â€¢ **NGT decompression:** 2 hours minimumâ”‚
â”‚ â€¢ **Clinical reassessment:** q4-6h     â”‚
â”‚ â€¢ **Maximum conservative trial:** 72h[27]â”‚
â”‚                                         â”‚
â”‚ [Next: Water-soluble contrast protocol â–¶]â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: CT Assessment]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3 â€“ Water-Soluble Contrast Protocol (Node L â†’ M)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§ª WATER-SOLUBLE CONTRAST PROTOCOL     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ’Š Gastrografin administration:         â”‚
â”‚ â€¢ **Dose:** 100mL undiluted Gastrografinâ”‚
â”‚ â€¢ **Route:** PO or via NGT              â”‚
â”‚ â€¢ **Timing:** After 2h NGT decompressionâ”‚
â”‚ â€¢ **Prerequisites:** No peritonitis, aspiration riskâ”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Therapeutic mechanism:               â”‚
â”‚ â€¢ **Hyperosmolar effect:** 1900 mOsm/L (6Ã— plasma)â”‚
â”‚ â€¢ **Fluid shift:** Into bowel lumen     â”‚
â”‚ â€¢ **Wall edema reduction**              â”‚
â”‚ â€¢ **Enhanced motility stimulation**     â”‚
â”‚                                         â”‚
â”‚ ğŸ“¸ Serial imaging protocol (SBFT):      â”‚
â”‚ â€¢ **Baseline:** Immediate post-contrast â”‚
â”‚ â€¢ **2 hours:** Early small bowel transitâ”‚
â”‚ â€¢ **8 hours:** Mid-transit assessment   â”‚
â”‚ â€¢ **24 hours:** Colonic arrival evaluationâ”‚
â”‚                                         â”‚
â”‚ âœ… Success indicators:                   â”‚
â”‚ â€¢ **Contrast in colon** within 24h      â”‚
â”‚ â€¢ **Clinical symptom improvement**       â”‚
â”‚ â€¢ **Decreased NGT output**              â”‚
â”‚ â€¢ **Return of bowel sounds**            â”‚
â”‚                                         â”‚
â”‚ [Next: SBFT interpretation â–¶]          â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Bologna Protocol]         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 4A â€“ SBFT Decision Point (Node O â†’ Q)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“Š SMALL BOWEL FOLLOW-THROUGH RESULTS   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â“ Contrast in colon within 24 hours?   â”‚
â”‚                                         â”‚
â”‚ âœ… **YES - Successful resolution:**     â”‚
â”‚ â€¢ 97% sensitivity for spontaneous resolutionâ”‚
â”‚ â€¢ Begin clear liquid diet               â”‚
â”‚ â€¢ Monitor for symptom recurrence        â”‚
â”‚ â€¢ Discontinue NGT when tolerating liquidsâ”‚
â”‚ â€¢ Advance diet as tolerated             â”‚
â”‚                                         â”‚
â”‚ âŒ **NO - Failed conservative management:**â”‚
â”‚ â€¢ Indicates persistent mechanical obstructionâ”‚
â”‚ â€¢ Proceed to 48-72h decision point      â”‚
â”‚ â€¢ Reassess clinical status              â”‚
â”‚ â€¢ Consider surgical consultation        â”‚
â”‚                                         â”‚
â”‚ ğŸ“ˆ Prognostic indicators:               â”‚
â”‚ â€¢ **Immediate colonic arrival:** Excellent prognosisâ”‚
â”‚ â€¢ **8h colonic arrival:** Good prognosisâ”‚
â”‚ â€¢ **No colonic arrival 24h:** Poor prognosisâ”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Clinical correlation required:       â”‚
â”‚ â€¢ Symptom improvement patterns          â”‚
â”‚ â€¢ NGT output trending                   â”‚
â”‚ â€¢ Physical exam changes                 â”‚
â”‚ â€¢ Laboratory parameter stability        â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 4B â€“ 48-72 Hour Decision Point (Node Q)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ â° CRITICAL DECISION POINT (48-72 HOURS) â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Bologna guidelines compliance[27]:   â”‚
â”‚ â€¢ **Conservative management:** 70-90% success rateâ”‚
â”‚ â€¢ **Maximum duration:** 72 hours safe  â”‚
â”‚ â€¢ **Delayed surgery:** Increases morbidity/mortalityâ”‚
â”‚                                         â”‚
â”‚ âœ… Improvement indicators:               â”‚
â”‚ â€¢ Patient reports feeling better        â”‚
â”‚ â€¢ NGT output decreasing trend <500mL/dayâ”‚
â”‚ â€¢ Tolerating small amounts of clear liquidsâ”‚
â”‚ â€¢ Passing flatus                        â”‚
â”‚ â€¢ Bowel sounds returning                â”‚
â”‚ â€¢ No fever or tachycardia              â”‚
â”‚                                         â”‚
â”‚ âš ï¸ Concerning indicators:               â”‚
â”‚ â€¢ Persistent or worsening pain          â”‚
â”‚ â€¢ Continued high NGT output >1000mL/day â”‚
â”‚ â€¢ Developing fever or leukocytosis      â”‚
â”‚ â€¢ New peritoneal signs                  â”‚
â”‚ â€¢ Rising lactate levels                 â”‚
â”‚                                         â”‚
â”‚ â“ Overall clinical trajectory?         â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ IMPROVING â†’ Continue conservative    â”‚
â”‚ ğŸ”˜ STATIC/WORSE â†’ Surgical consultation â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 5A â€“ Surgical Consultation (Node S â†’ V)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”ª SURGICAL CONSULTATION & PLANNING     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“ Consultation timing (evidence-based): â”‚
â”‚ â€¢ **Failed conservative management**     â”‚
â”‚ â€¢ **48-72h without improvement**[27]    â”‚
â”‚ â€¢ **Development of complications**       â”‚
â”‚ â€¢ **Patient/family preference**         â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Laparoscopic vs Open decision:       â”‚
â”‚ â€¢ **Laparoscopic preferred** if:        â”‚
â”‚   - First episode obstruction           â”‚
â”‚   - Hemodynamically stable              â”‚
â”‚   - No severe distension               â”‚
â”‚   - Simple adhesions expected           â”‚
â”‚   - AAST Grade I-II                     â”‚
â”‚                                         â”‚
â”‚ â€¢ **Open approach** if:                 â”‚
â”‚   - Multiple prior operations           â”‚
â”‚   - Suspected complex adhesions         â”‚
â”‚   - AAST Grade III-V                    â”‚
â”‚   - Hemodynamic instability            â”‚
â”‚   - Bowel necrosis suspected            â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Pre-operative optimization:          â”‚
â”‚ â€¢ Fluid resuscitation completion        â”‚
â”‚ â€¢ Electrolyte normalization             â”‚
â”‚ â€¢ Antibiotic prophylaxis[27]            â”‚
â”‚ â€¢ DVT prophylaxis                       â”‚
â”‚                                         â”‚
â”‚ [Next: Laparoscopic evaluation â–¶]      â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Decision Point Assessment] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 5B â€“ Laparoscopic Approach (Node V â†’ W)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”¬ LAPAROSCOPIC SBO MANAGEMENT (2025)   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ âœ… Advantages of laparoscopic approach: â”‚
â”‚ â€¢ **Faster recovery** vs open surgery   â”‚
â”‚ â€¢ **Reduced adhesion formation**        â”‚
â”‚ â€¢ **Better cosmetic outcomes**          â”‚
â”‚ â€¢ **Shorter hospital stay**             â”‚
â”‚ â€¢ **Lower infection rates**             â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Technical considerations:            â”‚
â”‚ â€¢ **Initial trocar placement:** Careful entryâ”‚
â”‚ â€¢ **Adhesiolysis technique:** Sharp dissection preferredâ”‚
â”‚ â€¢ **Energy devices:** Use cautiously (bowel injury risk)â”‚
â”‚ â€¢ **Conversion criteria:** Liberal conversion policyâ”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Conversion indications:              â”‚
â”‚ â€¢ **Dense adhesions** limiting visualizationâ”‚
â”‚ â€¢ **Bowel distension** preventing manipulationâ”‚
â”‚ â€¢ **Suspected perforation** requiring repairâ”‚
â”‚ â€¢ **Multiple obstructing bands**        â”‚
â”‚ â€¢ **Patient intolerance** of pneumoperitoneumâ”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Success predictors:                  â”‚
â”‚ â€¢ **Single adhesive band**              â”‚
â”‚ â€¢ **Early obstruction** (<48h symptoms) â”‚
â”‚ â€¢ **Minimal previous surgery**          â”‚
â”‚ â€¢ **Stable hemodynamics**               â”‚
â”‚                                         â”‚
â”‚ [Next: Post-operative care â–¶]          â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Surgical Planning]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6A â€“ Antibiotic Prophylaxis Protocol (Critical)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š ANTIBIOTIC PROPHYLAXIS (2025 UPDATE) â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¦  Small bowel obstruction prophylaxis[27]:â”‚
â”‚                                         â”‚
â”‚ **Non-obstructed small bowel:**         â”‚
â”‚ â€¢ **Cefazolin:** 2g IV (<120kg), 3g IV (â‰¥120kg)â”‚
â”‚ â€¢ **Redose interval:** q4h             â”‚
â”‚                                         â”‚
â”‚ **Obstructed small bowel:**             â”‚
â”‚ â€¢ **Cefazolin 2-3g IV + Metronidazole 500mg IV** (preferred)â”‚
â”‚ â€¢ **OR Cefoxitin 2g IV** q2h           â”‚
â”‚ â€¢ **OR Cefotetan 2g IV** q6h           â”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Alternative regimens (PCN allergy):   â”‚
â”‚ â€¢ **Clindamycin 900mg IV + Gentamicin 5mg/kg IV**â”‚
â”‚ â€¢ **Vancomycin 15mg/kg IV + Ciprofloxacin 400mg IV**â”‚
â”‚                                         â”‚
â”‚ â±ï¸ Timing considerations:               â”‚
â”‚ â€¢ **Within 60 minutes** before incision â”‚
â”‚ â€¢ **Vancomycin/Fluoroquinolones:** Start 60-120min beforeâ”‚
â”‚ â€¢ **Prolonged procedures (>3h):** Redose intraoperativelyâ”‚
â”‚                                         â”‚
â”‚ [Next: Post-operative monitoring â–¶]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6B â€“ Diet Advancement Protocol (Node P â†’ T)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ½ï¸ POST-RESOLUTION DIET ADVANCEMENT     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Advancement criteria met:            â”‚
â”‚ â€¢ **Contrast in colon** within 24h      â”‚
â”‚ â€¢ **Clinical symptom resolution**       â”‚
â”‚ â€¢ **NGT output** <200mL/8h              â”‚
â”‚ â€¢ **Return of bowel sounds**            â”‚
â”‚ â€¢ **No nausea or vomiting**            â”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Progressive diet protocol:           â”‚
â”‚ â€¢ **Step 1:** Clear liquids (4-6h)      â”‚
â”‚ â€¢ **Step 2:** Full liquids (if tolerated)â”‚
â”‚ â€¢ **Step 3:** Soft solids (next meal)   â”‚
â”‚ â€¢ **Step 4:** Regular diet (24h post-liquids)â”‚
â”‚                                         â”‚
â”‚ âš ï¸ Hold advancement if:                 â”‚
â”‚ â€¢ **Nausea/vomiting recurrence**        â”‚
â”‚ â€¢ **Abdominal pain increase**           â”‚
â”‚ â€¢ **Distension returns**                â”‚
â”‚ â€¢ **No flatus passage**                 â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Monitoring parameters:               â”‚
â”‚ â€¢ Tolerance of each diet level          â”‚
â”‚ â€¢ Bowel movement patterns               â”‚
â”‚ â€¢ Abdominal examination                 â”‚
â”‚ â€¢ Patient comfort level                 â”‚
â”‚                                         â”‚
â”‚ [Next: Discharge planning â–¶]           â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: SBFT Results]             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 7 â€“ Post-Operative Recovery (Node W â†’ X)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¥ POST-OPERATIVE RECOVERY PROTOCOL     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Enhanced recovery elements (ERAS):   â”‚
â”‚ â€¢ **Early NGT removal** (when output <500mL/day)â”‚
â”‚ â€¢ **Early mobilization** (within 24h)   â”‚
â”‚ â€¢ **Multimodal analgesia** (minimize opioids)â”‚
â”‚ â€¢ **DVT prophylaxis** continuation      â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Return of bowel function indicators: â”‚
â”‚ â€¢ **Passage of flatus**                 â”‚
â”‚ â€¢ **Bowel movement**                    â”‚
â”‚ â€¢ **Tolerance of clear liquids**        â”‚
â”‚ â€¢ **Reduced abdominal distension**      â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Complication surveillance:           â”‚
â”‚ â€¢ **Anastomotic leak** (if resection)   â”‚
â”‚ â€¢ **Wound infection**                   â”‚
â”‚ â€¢ **Ileus recurrence**                  â”‚
â”‚ â€¢ **Adhesion reformation**              â”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Diet advancement post-surgery:       â”‚
â”‚ â€¢ **Start when:** NGT removed + flatus  â”‚
â”‚ â€¢ **Progression:** Similar to conservative managementâ”‚
â”‚ â€¢ **Monitoring:** More frequent initiallyâ”‚
â”‚                                         â”‚
â”‚ [Next: Disposition planning â–¶]         â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Surgical Management]      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 8 â€“ Final Disposition & Quality Metrics (Node BB - Final)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“Š DISCHARGE PLANNING & QUALITY METRICS â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ âœ… Discharge criteria:                   â”‚
â”‚ â€¢ **Tolerating regular diet** >24h      â”‚
â”‚ â€¢ **Normal bowel movements**            â”‚
â”‚ â€¢ **Pain controlled** on oral meds      â”‚
â”‚ â€¢ **No fever** for 24h                  â”‚
â”‚ â€¢ **Stable laboratory values**          â”‚
â”‚                                         â”‚
â”‚ ğŸ“š Patient education priorities:         â”‚
â”‚ â€¢ **Diet progression** after discharge  â”‚
â”‚ â€¢ **Activity restrictions** (if post-op)â”‚
â”‚ â€¢ **Return precautions** (pain, vomiting, distension)â”‚
â”‚ â€¢ **Follow-up appointments** scheduled  â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Quality metrics (2025 standards)[27]: â”‚
â”‚ â€¢ **Bologna guidelines compliance:** Target >80%â”‚
â”‚ â€¢ **Conservative management success:** 70-90% targetâ”‚
â”‚ â€¢ **Appropriate surgical timing:** <72h for failed conservativeâ”‚
â”‚ â€¢ **Length of stay:** â‰¤5 days optimal   â”‚
â”‚ â€¢ **30-day readmission rate:** <15%     â”‚
â”‚                                         â”‚
â”‚ ğŸ“ Follow-up coordination:              â”‚
â”‚ â€¢ **Surgery follow-up:** 2 weeks (if operative)â”‚
â”‚ â€¢ **Primary care:** 1 week              â”‚
â”‚ â€¢ **Emergency return:** Clear instructionsâ”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Outcome tracking:                    â”‚
â”‚ â€¢ **Bologna guidelines compliance**      â”‚
â”‚ â€¢ **Conservative management success**   â”‚
â”‚ â€¢ **Patient satisfaction scores**       â”‚
â”‚ â€¢ **Cost-effectiveness measures**       â”‚
â”‚                                         â”‚
â”‚ âœ… BOWEL OBSTRUCTION PROTOCOL COMPLETE â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: All Treatment Pathways]   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

## VIRTUA VOORHEES BOWEL OBSTRUCTION ADDENDA

### **Enhanced RRT Response Program:**
- **Rapid Response Team:** Immediate access to general surgery and gastroenterology
- **Advanced Imaging:** 24/7 CT capability with expert radiologist interpretation
- **Bologna Protocol Implementation:** Standardized conservative management pathways
- **Quality Metrics:** Compliance tracking with evidence-based guidelines, length of stay optimization

### **2025 Evidence Integration:**
**Bologna Guidelines Compliance Benefits[27]:**
- **Conservative management success:** 70-90% with proper protocol adherence
- **Reduced unnecessary surgery:** Up to 30% reduction in operative interventions
- **Length of stay optimization:** 5.3 days vs 12.9 days with protocol compliance
- **Morbidity reduction:** Lower complication rates with standardized approach

**Water-Soluble Contrast Protocol Benefits:**
- **97% sensitivity** for predicting spontaneous resolution when contrast reaches colon within 24h
- **Therapeutic effect:** Hyperosmolar fluid shift reduces bowel wall edema
- **Early decision making:** Allows for timely surgical intervention when needed

### **AAST Grading System Integration (2025):**
**Grade-Based Management:**
- **Grade I-II:** Conservative management appropriate
- **Grade III:** Intensive monitoring, early surgical consideration
- **Grade IV-V:** Immediate surgical intervention required
- **Prognostic value:** Higher grades correlate with increased morbidity/mortality

**Quality Improvement Applications:**
- **Standardized communication:** Universal grading terminology
- **Risk stratification:** Predicts outcomes and resource needs
- **Research applications:** Enables comparative effectiveness studies

### **Laparoscopic Approach Optimization (2024-2025):**
**Patient Selection Criteria:**
- **Ideal candidates:** First episode, hemodynamically stable, minimal distension
- **Success predictors:** Single adhesive band, early presentation, minimal prior surgery
- **Conversion planning:** Liberal policy acceptable (conversion rates 20-50%)

**Technical Considerations:**
- **Trocar placement:** Careful assessment for safe entry points
- **Adhesiolysis technique:** Sharp dissection preferred over electrocautery
- **Conversion threshold:** Patient safety prioritized over laparoscopic completion

### **Advanced Technology Integration:**
**Enhanced Imaging Protocols:**
- **Multidetector CT:** 95% sensitivity for high-grade obstruction
- **IV contrast timing:** Optimal visualization of transition points
- **3D reconstruction:** Improved surgical planning capabilities

**Clinical Decision Support:**
- **Bologna compliance tracking:** Automated reminders and protocols
- **Risk stratification tools:** Predictive models for surgical need
- **Electronic monitoring:** NGT output, fluid balance, clinical parameters

### **Quality Improvement Metrics (2025 Standards):**
**Process Measures:**
- **Bologna guideline compliance:** Target >80% adherence
- **Appropriate conservative trials:** 72h maximum duration
- **Water-soluble contrast utilization:** Standard protocol implementation
- **Surgical consultation timing:** Within 72h of failed conservative management

**Outcome Measures:**
- **Conservative management success:** Target 75% (range 70-90%)
- **Length of stay:** â‰¤5 days for optimal outcomes
- **30-day readmission:** <15% target
- **Surgical site infection:** <5% for elective cases

### **Patient Population Considerations:**
**Elderly Patients (>75 years):**
- **Higher surgical risk:** Conservative management preferred when safe
- **Comorbidity assessment:** Cardiac, pulmonary, renal function evaluation
- **Goals of care:** Quality vs quantity discussions with family
- **Nutritional support:** Earlier consideration of parenteral nutrition

**Recurrent Obstruction Management:**
- **Adhesion prevention:** Consider anti-adhesion barriers during surgery
- **Pattern recognition:** Identify patients at high recurrence risk
- **Prophylactic measures:** Lifestyle modifications, dietary counseling
- **Long-term follow-up:** Specialized adhesion clinics

### **Medication Safety & Perioperative Management:**
**Enhanced Recovery After Surgery (ERAS):**
- **Pre-operative optimization:** Carbohydrate loading, minimal fasting
- **Multimodal analgesia:** Acetaminophen, NSAIDs, regional blocks
- **Early mobilization:** Within 24h post-operatively
- **Fluid management:** Goal-directed therapy avoiding overload

**Antibiotic Stewardship:**
- **Prophylaxis duration:** Single dose for most procedures
- **Therapeutic antibiotics:** Only if signs of infection/perforation
- **Culture-directed therapy:** When infection present
- **Resistance prevention:** Appropriate agent selection

### **Team-Based Care Integration:**
**Multidisciplinary Approach:**
- **Surgery:** Early involvement for risk stratification
- **Gastroenterology:** Complex cases, recurrent obstruction evaluation
- **Radiology:** Advanced imaging interpretation, intervention planning
- **Pharmacy:** Antibiotic optimization, pain management protocols

**Communication Protocols:**
- **Surgery consultation:** Within 4h of diagnosis for high-risk features
- **Daily rounds:** Multidisciplinary assessment with Bologna protocol review
- **Family updates:** Regular communication about conservative vs operative approach

### **Research & Future Directions:**
**Emerging Technologies (2025-2026):**
- **AI imaging analysis:** Automated obstruction severity scoring
- **Predictive modeling:** Machine learning for surgical timing optimization
- **Biomarkers:** Novel laboratory tests for strangulation prediction
- **Enhanced recovery protocols:** Personalized ERAS pathway implementation

**Clinical Research Integration:**
- **Bologna compliance studies:** Ongoing quality improvement initiatives
- **Laparoscopic technique refinement:** Equipment and approach optimization
- **Water-soluble contrast alternatives:** Novel agents under investigation
- **Adhesion prevention research:** Barrier effectiveness studies

### **Cost-Effectiveness & Value-Based Care:**
**High-Value Interventions:**
- **Bologna protocol compliance:** Reduces inappropriate surgery rates by 30%
- **Water-soluble contrast use:** Enables early decision making, reduces length of stay
- **Laparoscopic approach:** Faster recovery, reduced complications when appropriate
- **Standardized pathways:** Reduces practice variation and associated costs

**Resource Optimization:**
- **Appropriate imaging utilization:** CT only when clinically indicated
- **Conservative management:** Prevents unnecessary surgery costs
- **Length of stay management:** Early discharge protocols for successful conservative management
- **Readmission prevention:** Comprehensive discharge planning and follow-up

### **Integration with Other Protocols:**
- **Sepsis Protocol:** For patients developing complications
- **Pain Management Protocol:** Multimodal approaches avoiding opioid dependence
- **Nutrition Protocol:** For prolonged conservative management cases
- **Enhanced Recovery Protocol:** Post-operative ERAS pathways

### **Patient Education & Family Support:**
**Pre-Treatment Education:**
- **Conservative vs surgical options:** Clear explanation of Bologna protocol
- **Timeline expectations:** Realistic duration estimates for conservative management
- **Warning signs:** When to alert medical team of concerning symptoms
- **Family involvement:** Role in supporting conservative management

**Post-Treatment Education:**
- **Diet advancement:** Gradual progression instructions
- **Activity restrictions:** Post-operative or post-conservative management limitations
- **Return precautions:** Signs requiring emergency evaluation
- **Long-term prevention:** Strategies to reduce recurrence risk

## REFERENCE GUIDELINES
- **2025 World Society of Emergency Surgery (WSES) Updated Bologna Guidelines for Adhesive Small Bowel Obstruction**
- **2025 American College of Surgeons Updated Clinical Practice Guidelines for Small Bowel Obstruction**
- **2025 Prospective Multi-Center Study on Compliance with Bologna Guidelines (SnapSBO)**
- **2024 European Association for Endoscopic Surgery Guidelines on Laparoscopic Management of SBO**
- **Virtua Health System Bowel Obstruction Protocol v2025**

**This comprehensive protocol integrates the latest evidence-based bowel obstruction management with enhanced Bologna guideline compliance, AAST grading system integration, advanced water-soluble contrast protocols, optimized surgical decision-making, and comprehensive quality metrics optimized for excellent patient outcomes at Virtua Voorhees.**
